850 related articles for article (PubMed ID: 16637860)
1. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
[TBL] [Abstract][Full Text] [Related]
3. Clinical, virologic and pathologic significance of elevated serum gamma-glutamyl transpeptidase in patients with chronic hepatitis C.
Hwang SJ; Luo JC; Lai CR; Chu CW; Tsay SH; Lu CL; Wu JC; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):527-35. PubMed ID: 10934805
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ
Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.
Göbel T; Erhardt A; Herwig M; Poremba C; Baldus SE; Sagir A; Heinzel-Pleines U; Häussinger D
J Med Virol; 2011 Jun; 83(6):968-73. PubMed ID: 21503908
[TBL] [Abstract][Full Text] [Related]
6. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
7. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
9. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
10. Serum adiponectin in chronic hepatitis C and B.
Siagris D; Vafiadis G; Michalaki M; Lekkou A; Starakis I; Makri M; Margaritis V; Christofidou M; Tsamandas AC; Labropoulou-Karatza C
J Viral Hepat; 2007 Aug; 14(8):577-83. PubMed ID: 17650292
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
[TBL] [Abstract][Full Text] [Related]
12. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease.
Sumi H; Yokosuka O; Seki N; Arai M; Imazeki F; Kurihara T; Kanda T; Fukai K; Kato M; Saisho H
Hepatology; 2003 Jan; 37(1):19-26. PubMed ID: 12500184
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity.
Lesmana LA; Lesmana CR; Pakasi LS; Krisnuhoni E
Acta Med Indones; 2012 Jan; 44(1):35-9. PubMed ID: 22451183
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases.
Zarski JP; Marcellin P; Leroy V; Trepo C; Samuel D; Ganne-Carrie N; Barange K; Canva V; Doffoel M; Cales P;
J Hepatol; 2006 Sep; 45(3):355-60. PubMed ID: 16750585
[TBL] [Abstract][Full Text] [Related]
15. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
Kita Y; Mizukoshi E; Takamura T; Sakurai M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
Metabolism; 2007 Dec; 56(12):1682-8. PubMed ID: 17998021
[TBL] [Abstract][Full Text] [Related]
16. e-antigen-negative chronic hepatitis B in Bangladesh.
Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
[TBL] [Abstract][Full Text] [Related]
19. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
Ramakrishna B; Mukhopadhya A; Kurian G
J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
[TBL] [Abstract][Full Text] [Related]
20. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.
Tsochatzis E; Papatheodoridis GV; Manolakopoulos S; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2009; 44(6):752-9. PubMed ID: 19296398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
